text:
Welcome to Direct Automotive Transport where we sell quality pre-owned vehicles in Monroe, NC. We offer excellent and competitive finance rates on our entire inventory. With several years of experience in the industry we have earned an exceptional reputation based on hard work, honesty, and excellent customer service.
We provide our customers with the complete information on any vehicle they are interested in and will help them find the perfect automobile that will suit their specific needs. No matter what make or model of vehicle you are searching for you are sure to find it at
our dealership. We also offer great financial services
for those who qualify.
Simply click on the Inventory link above, pick the
vehicle you're looking for, fill out the secure
Credit Application if you would like to apply for
credit, and we'll do the rest.


text:
More Details: Military Naval Aviator Pin-On Insignia is a brass plated Insignia. This Stylish Naval Aviator Pin has been made in the USA and features a pin closure. Designed by Captain Henry C. Mustin, the Naval Aviator Insignia is a warfare qualification of the United States military that is awarded to those aviators of the United States Navy, Marine Corps, and Coast Guard who have qualified as Naval Aviators upon successful completion of flight school.
Any Questions?
Naval Aviator Pin
Your Name:
Friend's Email:
Your Message:
Call Us : 201-815-4327
Our staff is ready to answer all your questions or concerns.
Product Reviews:
Naval Aviator Pin
Current Reviews: 0
Please tell us what you think and share your opinion with others. Be sure to focus your comments on the product.
Submit Review
Did you purchase this product? Write your opinion and help the others by sharing the information.

subset: commoncrawl


text:
Research News
Prostate Cancer Research
News: Research and Therapeutics
More Research News
- 9/22/2015Relaxed Guidelines on PSA Testing Might Miss Aggressive Tumors: Study | Men who could be cured of more advanced prostate disease may be diagnosed late, some researchers say
- 7/17/2015Study Questions Radiation Use for 'Low-Risk' Prostate Cancers | Upping the dosage didn't alter survival rates for men with these slow-growing tumors.
- 6/24/2015A New Genomic Classifier Enables Diagnosis of the Aggressive Neuroendocrine Subclass of Treatment-Resistant Prostate Cancer | Tumors that express neuro-developmental markers are of the most highly aggressive subsets of treatment-resistant prostate cancer and have a unique biology that requires novel study and treatment options.
- 6/09/2015Earlier Chemotherapy May Extend Patient Survival in Multiple Prostate Cancer Settings | Earlier treatment with taxane chemotherapy may prolong survival.
- 6/02/2015The Discovery of New Molecular Mechanisms that May Link Obesity and High Risk Prostate Cancer | Obesity is known to increase the risk for prostate cancer, particularly for high-risk, lethal disease.
- 5/26/2015The PARP-Inhibitor Olaparib May Be the First Precision Medicine Therapy to Reach Prostate Cancer Patients | At the 2015 Annual AACR meeting, results presented from the Phase II TO-PARP clinical trial.
- 5/21/2015The Prostate Cancer Foundation-International Prostate Cancer Dream Team demonstrates the value of cancer precision medicine strategies | Prostate cancer patients continue to be treated with cookie-cutter therapies.
- 5/17/2015Prostate Cancer Testing Drops Off Following Controversial Guidelines | More men will die without PSA screening, researchers contend; other experts applaud the downward trend
- 5/14/2015Early Chemo May Boost Survival in Advanced Prostate Cancer | Study found combination with hormone therapy extended life by almost a year
- 5/14/2015Radiation Plus Hormone Therapy May Help Some Prostate Cancer Patients | Study found five-year death risk was 50 percent lower in combo-treatment group
- 5/7/2015Statins May Slow Prostate Cancer Progression: Study | But more trials are needed to confirm benefits, experts say
- 4/22/2015New Technology Tests Tumors Inside the Patient to Find Best Treatment | Experiment devices might reduce risk of side effects, lower costs, researchers say
- 3/30/2015Report Shows Progress in America's War on Cancer | Small, but steady declines in deaths seen over past decade
- 3/10/2015Statins May Help Improve Prostate Cancer Survival: Study | Finds the cholesterol-lowering drugs linked to slower progression of disease
- 2/24/2015Did PSA Test's Decline Spur Rise in Prostate Cancers? | Researchers report 3 percent annual rise in intermediate- and high-risk cases.
- 2/23/2015Watch-and-Wait Strategy May Be Riskier for Certain Prostate Cancers | Study found lower survival for intermediate-risk disease, compared to low-risk cases.
- 2/23/2015Testicular Cancer May Raise Prostate Cancer Risk: Study | But it's too soon to make any recommendations, and overall risk is low, researcher says.
- 2/19/2015More Americans Surviving Cancer Today Than 20 Years Ago | Study shows biggest improvements in people diagnosed between ages 50 and 64.
- 2/19/2015Are Too Many Prostate Cancer Patients Receiving Treatment? | Study also raises concerns about possible overuse of radiation therapy.
- 1/27/2015MRI Improves Prostate Cancer Biopsy Accuracy, Study Finds | New technology spots more aggressive cancer, but fewer low-risk cases
- 1/07/2015Strategy Might Thwart Resistance to a Common Prostate Cancer Treatment | Small study suggests that alternating testosterone levels may make hormonal therapy work longer
- 9/17/2014DNA Blood Test Might Identify Status of Prostate Cancer | May help doctors pinpoint best treatment, researchers say
- 9/15/2014New Gene Variants for Prostate Cancer Identified | 23 new variants associated with increased risk of the disease, study shows
- 9/15/2014Male Pattern Baldness Tied to Prostate Cancer, Study Suggests | Testosterone might be the link between the two, but more research needed to prove a connection
July, 2014
- 7/14/2014Depression May Make It Harder to Beat Prostate Cancer | Men with both conditions have worse survival odds, study contends
- 7/2/2014Making Science Real: Scientists Moving Forward in Addressing Research Integrity; Learning from Past Mistakes | Poor scientific reproducibility is a product of poor reagents, sloppiness, selective publishing of data, and on occasion – outright fraud.
June, 2014
- 6/5/2014The Prostate Cancer Foundation Congratulates PCF Investigator Dr. Nima Sharifi on his 2014 award from the AACR for Outstanding Achievement in Cancer Research | At the 2014 AACR Annual Meeting, Prostate Cancer Foundation Investigator Dr. Nima Sharifi was honored with the 34th Annual AACR Award for Outstanding Achievement in Cancer Research
- 6/5/2014The Prostate Cancer Foundation Congratulates PCF Investigator Dr. Levi Garraway on both his AACR award—the Jane Cooke Wright Lectureship, and his Paul Marks Prize for Cancer Research from Memorial Sloan-Kettering Cancer Center | Prostate Cancer Foundation-funded Investigator Dr. Levi A. Garraway takes home two awards: The Jane Cooke Wright Lectureship Award at the 2014 AACR Annual Meeting & Memorial Sloan-Kettering Cancer Center's Paul Marks Prize for Cancer Research
- 6/5/2014How the immune system can be harnessed to kill cancer | Understanding and improving on immunotherapies was a major focus at the 2014 AACR Annual Meeting.
May, 2014
- 5/29/2014Advances in Prostate Cancer Research from the 2014 AACR Annual Meeting | At the 2014 AACR Annual Meeting held in San Diego, CA this spring, Prostate Cancer Foundation-funded investigators discussed recent progress and exciting new studies regarding prostate cancer biology and treatment.
- 5/14/2014Finding Cancer Solutions, One Cell at a Time | Hot new technologies and methods are making leaps forward in studying individual cancer cells—which will help prevent drug resistance to therapy and identify new drug targets
March, 2014
- 3/28/2014PCF researchers discover molecular crosstalk that prostate cancer cells use to survive radiation therapy; plan steps to halt that "conversation" | Prostate Cancer Foundation-funded researchers published two studies this fall that help explain why androgen deprivation therapy improves survival when given with radiation therapy
- 3/27/2014 Slight Drop in Rate of Advanced Cancers, CDC Says | Number of cases where tumors have spread beyond origins declined, but experts say more can be done
February, 2014
- 2/18/2014 "Delivering a Triple-Knockout Punch to Prostate Cancer—A novel cancer immunotherapy approach receives a $1 million Movember-Prostate Cancer Foundation Challenge Award" | Coaxing our natural immune system to fight off cancer cells in the body has been historically and frustratingly difficult
January, 2014
- 1/28/2014 Drug May Extend Survival for Men With Advanced Prostate Cancer | Study participants hadn't received any treatment with chemotherapy
- 1/16/2014 Patient-Centered Drug Development (video) | Doc, How will this this anti-cancer drug make me feel?
- 1/10/2014 Two-thirds of new FDA-approved drugs to treat prostate cancer driven by Prostate Cancer Foundation support | The Journal of Clinical Oncology has just published an item detailing the Prostate Cancer Foundation's deep involvement in bringing new drugs against prostate cancer to market
- 1/10/2014 An Aspirin a Day to Keep the Prostate Cancer at Bay? | PCF Young Investigator, Dr. Jennifer R. Rider of Brigham and Women's Hospital and the Harvard School of Public Health looks into what impact aspirin therapy might have on prostate cancer
- 1/9/2014 Geraldine Gueron, a Prostate Cancer Foundation Young Investigator, has been named by MIT Technology Review as a Top Innovator Under 35 for 2013 | The Massachusetts Institute of Technology's Technology Review 35, or MIT TR35, award is an "annual celebration of people who are driving the next generation of technological breakthroughs."
October, 2013
- 10/30/2013 Promising Nanomedicine Advances to Phase II Clinical Trials | Docetaxel has long been used to treat advanced forms of prostate cancer; now an ingenious targeted drug platform will deliver this chemotherapeutic directly to tumors, allowing higher dosing with fewer side effects
- 10/24/2013 Cool Technology: Stretchy Electronics and Sensors that Can Dissolve in Your Body | A 21st century interface of engineering and oncology may bring better medicine to patients. Learn about electoceuticals and how they may help prevent infections, and why next-generation electronics that can stretch to fit over catheters or dissolve once no longer needed may benefit patients
July, 2013
- 7/24/2013 Subtype of Highly Aggressive Prostate Cancer Increasing; Tied to Drug Resistance to Hormone Therapy | Novel drug being tested in multi-site Phase II clinical trial to treat men with this aggressive form of prostate cancer known as neuroendocrine prostate cancer
- 7/24/2013 Xofigo Results Published in New England Journal of Medicine – Explanatory Video Accompanies Publication | Explanatory Video Accompanies Publication | The Prostate Cancer Foundation has repeatedly reported on this drug's development and movement to market
- 7/2/2013 Breakthrough in Nano-Medicine Chemotherapy Drug Delivery in Phase II Trials | Think of this nanoparticle technology as a Chemotherapy ExpressLine Bus Service
June, 2013
- 6/24/2013 With FDA-approval of Xofigo, many men with advanced prostate cancer can expect improved quality of life (Video) | Listen as Doctors Discuss Xofigo in greater detail
- 6/10/2013 Prolaris Prostate Cancer Test Highly Predictive of Tumor Lethality | Summary Results of five studies of test presented at this year's ASCO meeting in Chicago
- 6/4/2013 Personalizing Cancer Care: PARP Inhibitor + Hormone Therapy for Advanced Prostate Cancer | Study to determine if prostate cancer patients with prevalent gene-fusion mutation benefit from addition of PARP inhibitors to Hormone Therapy
May, 2013
- 5/23/2013 New Genetic Test to Diagnose Highly Lethal Form of Prostate Cancer Enters Commercial Development; May Lead to Increased Survival | The occurrence of a rare and highly aggressive form of prostate cancer known as neuroendocrine prostate cancer (NEPC) is increasing
- 5/20/2013 A Layman's Guide to Prostate Cancer Genes | Prostate Cancer Genes Begin to Tell Their Story
- 5/15/2013 Another new drug that extends survival time for men with advanced prostate cancer gains FDA approval | Xofigo (radium-223) is the second prostate cancer drug to treat metastatic disease that has come to market during the past year; the first bone-targeted drug to improve survival
- 5/13/2013 Taking the Lethal out of Prostate Cancer; plus Entirely New Class of Drug Shows Promise Against Advanced Disease (video) | Entirely New Class of Drug Shows Promise Against Advanced Prostate Cancer
- 5/8/2013 New Test Can Better Tell Need For Surgery vs. Active Surveillance | Prostate Cancer Foundation funded early research that underpinned test's development.
- 5/8/2013 New 17-gene test enhances ability to predict aggressiveness of prostate cancer; may spare men unnecessary surgery/radiation | Prostate Cancer Foundation funded early research that underpinned test's development
- 5/2/2013 Statins May Reduce Prostate Cancer Deaths | The role of statins in mitigating prostate cancer risks has been debated often during the past few years
April, 2013
- 4/26/2013 Can Botox Tame Prostate Cancer? | Botox shriveled tumor cells in men prior to surgery; injections of the drug into tumor may enhance effects of radiation therapy
- 4/25/2013 Zytiga is Most Used First-Line Treatment for Stage IV Prostate Cancer | Market data released this week shows the new drug's share of the first-line prostate cancer market has steadily increased to 30 percent since its launch in 2011
- 4/22/2013 News Roundup—prostate cancer news makes headlines at the annual meeting of the American Association for Cancer Research | Selenium-Prostate Cancer Link Again Under Debate
- 4/22/2013 Cancer Centers Race to Map Patient's Genes | Researchers now acknowledge that studying the few 'exceptional responders' in failed clinical trials can yield new insights into cancer
- 4/19/2013 Cancer Researchers Revisit 'Failed' Clinical Trials and Begin Study of the One to Ten Percent of Patients Who Responded to Treatment | The ability to map the genes of cancer patients and determine the specific genotype (variety) of their tumors is rapidly moving
- 4/15/2013 Prostate Cancer Foundation Young Investigators Advance Cancer Research at the 2013 AACR in Washington | This year, AACR presentations related to prostate cancer were chock full of Prostate Cancer Foundation Young Investigators
- 4/8/2013 Rally for Medical Research | The Prostate Cancer Foundation (PCF) is one of over 200 partnering organizations supporting this important event.
- 4/5/2013 Third-Generation Device Significantly Improves Capture of Circulating Tumor Cells | A new system for isolating rare circulating tumor cells (CTCs) -- living solid tumor cells found at low levels in the bloodstream -- shows significant improvement over previously developed devices and does not require prior identification of tumor-specific target molecules
- 4/5/2013 Study Changes the Way Doctors Practice | A new study shows that continuous hormone therapy (androgen deprivation therapy) helps men more than intermittent or pulsed hormone therapy.
- 4/5/2013 The Link Between Early Baldness and Prostate Cancer | Researchers have long known about the potential link between baldness and the risk of prostate cancer, but studies have been conflicting
- 4/3/2013 A Year After Common, Novel SPOP Prostate Cancer Gene Mutation Identified, Researchers Determine Its Route to Cancer | When SPOP is mutated it no longer can act as a tumor suppressor gene
March, 2013
- 3/13/2013 Delivering on the Promise to Young Scientists | The young do not know enough to be prudent
- 3/8/2013 Markers May Indicate Occult High-Grade Prostate Cancer | Epigenetic changes in benign tissue sampled during prostate biopsy confirmed as "field effect" biomarkers of undetected tumor
February, 2013
- 2/11/2013 More Data Links Prostate Cancer With Dairy Consumption | Prior studies have shown that higher overall milk intake is associated with a greater risk of developing prostate cancer
- 2/01/2013 PCF-Funded Investigator to Lead New Institute for Precision Medicine | Precision medicine is the ultimate goal in treating prostate cancer so we can cure more and overtreat less
January, 2013
- 1/25/2013 New Y Chromosome Research Yields Insight Into Prostate Cancer Development | A large international 10-year project launched last year, titled the Human Proteome Project, ambitiously aims to map all proteins produced by genes on human chromosomes
- 1/24/2013Cost-Effectiveness Study Compares Surgery and Radiation Therapy for Localized Prostate Cancer—Small Differences in Outcomes, Big Differences in Cost | Dr. Cooperberg explains that they ran and reran the men through their various treatment algorithms and that a certain number of men would wind up in each possible health state
- 1/22/2013 Investigational Agent Orteronel (TAK700) Holds Promise in the Post-Abiraterone, Post-Enzalutamide Era | The past year has been exciting for prostate cancer patients with newer, more potent agents such as abiraterone and enzalutamide being added to the prostate cancer treatment armamentarium
- 1/17/2013 Focal Therapy for Prostate Cancer Explained in Research Review | Researchers from Duke University Medical Center studied the evolution of focal therapy as a reasonable option for men with clinically localized, low-grade disease
- 1/15/2013 Kaiser Permanente Study Finds Changes in Prostate Specific Antigen Levels over Time can Help Predict Aggressive Prostate Cancer | Measurements taken over time of prostate specific antigen, the most commonly used screening test for prostate cancer in men
- 1/14/2013 Mapping PCa's Genetic Landscape Just Got a Bit Easier and Potentially Less Expensive | Cancer genetics researchers study tumors for clues; they want to know how the tumor got there in the first place
- 1/8/2013 New Center for Prostate Cancer to be led by PCF Researcher Dr. Ashutosh Tewari | Researcher, mentor and long-time friend to PCF, Dr. Ashutosh Tewari will lead the new Center for Prostate Cancer at New York-Presbyterian/Weill Cornell Medical Center
December, 2012
- 12/21/2012 Prostate Cancer: What Did We Learn From the 2012 Annual Scientific Meeting of ASCO? | In recent years, management of prostate cancer has benefited from an expanding array of new pharmacological options
- 12/20/2012 Epigenetics and Cancer | An Enzyme's Functional Switch May Fuel Treatment-Resistant Prostate Cancer; Drug Target More Clearly Limned
- 12/19/2012 New England Journal of Medicine Publishes Positive Phase III Clinical Results for Zytiga (abiraterone) in Men Without Prior Chemotherapy—Should Bolster Medical Reimbursements | The study was a multinational, double-blind, randomized evaluation of 1,088 men assigned to receive either Zytiga and prednisone, or placebo plus prednisone.
- 12/18/2012 California a Leading State for Research Into Cancer Afflicting Gov. Brown | The study was a multinational, double-blind, randomized evaluation of 1,088 men assigned to receive either Zytiga and prednisone, or placebo plus prednisone
- 12/17/2012 First Patient Inducted into Phase II Clinical Trial Evaluating Galeterone | Building on the success of Phase I clinical trials, Tokai Pharmaceuticals has advanced its lead prostate cancer drug for the treatment of advanced disease into Phase II trials this week.
- 12/11/2012 Childhood Leukemia Researcher Makes Headlines, Now Works toward Prostate Cancer | One of the biggest challenges of prostate cancer is the diagnostic process, with respect to both finding tumors within the prostate and obtaining the most precious biopsy samples
- 12/11/2012 Promising Phase III Clinical Trial Successfully Enrolls 1,200 Patients | Tasquinimod, or TASQ, is an oral experimental treatment for men with metastatic treatment resistant prostate cancer
- 12/07/2012 Common Bacteria Examined in Prostatectomy Samples | In this preclinical study, the researchers found that their novel drug was indeed activated by PSA in prostate cancer cells and lead to P13K inhibition and cancer cell death
- 12/04/2012 Promising Results for 1st Prostate Cancer-Targeted Prodrug Against Signaling Pathway (PI3K) Associated with Substantial Number of Prostate Tumors | In this preclinical study, the researchers found that their novel drug was indeed activated by PSA in prostate cancer cells and lead to P13K inhibition and cancer cell death
- 12/03/2012 PET Scans to Image Prostate Cancer Advance Toward Mainstream Clinical Use | This project was partially supported by a PCF Creativity Award made possible through generous support of Movember
November, 2012
- 11/29/2012 The Microfluidic VerIFAST | On October 26, 2012, PCF-funded Young Investigator Joshua Lang, MD presented data on the VerIFAST platform and the development of circulating tumor cell isolation and staining technology.
- 11/29/2012 Vitamin D Mechanism of Action Discovered by McGill University | Vitamin D has long been believed to play an important role in prostate and other cancers, though its mechanism of action had yet to be verified.
- 11/26/2012 Epigenetics and Prostate Cancer – New Findings May be of Particular Importance for Men Lacking a Common Genetic Fusion Abnormality | Determining what drives prostate cancer development and progression is the key to finding ways to alter than course and prevent deaths from this disease.
- 11/16/2012 Glutamate, an Agent in Cancer Metabolism, Identified as a Biomarker for Prostate Cancer | There is a critical unmet medical need to identify disease biomarkers that can efficiently report on the underlying biology of an individual patient's cancer.
- 11/16/2012 Prostate Cancer Antibody Attacks Metastatic, Treatment-Resistant Disease | Daniel Petrylak, MD, of Yale University Medical Center and a past PCF-funded investigator, led a research study evaluating an antibody-drug that targets prostate-specific membrane antigen (PSMA)
- 11/16/2012 Recurrent Prostate Cancer May Be Explained Through Deeper Understanding of Androgen Receptor | Androgens are male hormones that fuel the growth and spread of prostate cancer
- 11/16/2012 Bar Code Tests Spot Aggressive Prostate Cancers | Aside from curing prostate cancer, the holy grail of this disease is to determine which cancers require aggressive treatments
- 11/1/2012 Memorial Sloan-Kettering Researchers Discover Prostate Cancer Disease Pathways Regulate Each Other | Researchers discover a specific combination of inhibitors which cause tumor recession in mouse models.
October, 2012
- 10/26/2012 Stat5 Predicts Early Disease Recurrence and Prostate Cancer Specific Deaths in Patients After Radical Prostatectomy | There is an urgent unmet medical need to identify robust markers to identify patients whose prostate cancer will recur after initial treatment and progress to aggressive disease.
- 10/26/2012 Mystery of Trop2 Protein Unveiled | The proteinTrop2 has long been considered a vital component to understand disease progression in several cancers.
- 10/5/2012 New Data Shows Added Benefits for Prostate Cancer Drug Enzalutamide | From this year's European Society for Medical Oncology (ESMO) Congress in Vienna September 28-October 2, 2012
- 10/5/2012 Novel Anti-androgen Drug Shows Potential Anticancer Effects in 87% of Men with Advanced Form of Prostate Cancer in Early Clinical Testing | From this year's European Society for Medical Oncology (ESMO) Congress in Vienna September 28-October 2, 2012
- 10/4/2012 Common Drug Used to Treat Diabetes May Benefit Subset of Prostate Cancer Patients | From this year's European Society for Medical Oncology (ESMO) Congress in Vienna September 28-October 2, 2012
- 10/4/2012 Novel Anti-Sense Drug Lowers PSA Levels and Delays Disease Progression in a Phase II Clinical Trial | From this year's European Society for Medical Oncology (ESMO) Congress in Vienna September 28-October 2, 2012
- 10/2/2012 Protein Found in Prostate Cancer May Promote Cancer Growth and Progression | The protein PARP1 is known to play a crucial role in DNA repair.
- 10/2/2012 Novel Radiopharmaceutical Shows Survival and Quality of Life Benefit to Men with Metastatic PCa | From this year's European Society for Medical Oncology (ESMO) Congress in Vienna September 28-October 2, 2012
- 10/1/2012 The War on Cancer Reboots | It's been a fight that has been going on for four decades, but new technologies are allowing us to get a better understanding of how cancers work, reports Alex Philippidis in Streetwise's Life Sciences Report.
September, 2012
- 9/26/2012 MD Anderson Cancer Center Initiates "Moon Shot" Program to Increase Patient Survival over Coming Decade | According to MD Anderson president Ronald DePinho, the institution has "tens of millions of dollars" to get started and plans to spend up to $3 billion over the next 10 years.
August, 2012
- 8/10/2012 PCF-Funded Young Investigator Awarded by University for Exemplary Research Progress Made in Prostate | 2010 LeFrak Family PCF Young Investigator Dr. Himisha Beltran, assistant professor of medicine at Weill Cornell Medical College, was honored by the institution with The 21st Annual Department of Medicine Investigator Award.
- 8/8/2012 Study Questions Value of Calcium and Vitamin D Supplements for Certain Men with Prostate Cancer | Prescribing calcium and vitamin D supplements for men at risk of bone loss from hormonal treatment for prostate cancer seems like good medicine.
- 8/6/2012 Edinburgh Study Pinpoints Prostate Cancer 'Growth' Gene | Scientists from Edinburgh University have pinpointed a gene they say could lead to improvements in the diagnosis and treatment of prostate cancer.
July, 2012
- 7/25/2012 Phase III Clinical Trial Opens In Republic of South Africa, Enrolls First Patient | The first prostate cancer patient enrolled in a Phase III clinical trial and began receiving treatment on the investigational therapeutic agent Debio 8206.
- 7/25/2012 Protein Brings New Light to Understanding Prostate Cancer | The holy grail of prostate cancer is to figure out why cells stop responding to hormone therapy.
- 7/18/2012 Landmark Study Comparing Surgical Intervention to Watchful Waiting in Men With Low Risk Prostate Cancer Shows Certain Men May Safely Forgo Surgery | The study shows that a subset of men who are properly selected can safely choose either active surveillance or a watchful waiting management approach of their diagnosed prostate cancers
- 7/16/2012 New Cancer Biomodule Regulating Prostate Cancer Initiation and Progression Identified | Proteins in the Hox regulatory network identified as potential tumor suppressors in prostate cancer initiation and progression.
- 7/6/2012 TMPRSS2-ERG and Prostate Cancer Outcomes after Prostatectomy | New study shows common prostate cancer mutation does not strongly predict disease recurrence or mortality among men treated with radical prostatectomy
June, 2012
- 6/20/2012 Major Advancements Being Made Against Prostate Cancer, says FDA Cancer Drug Chief | For many cancer patients, treatment options remained in a holding pattern for far too long.
- 6/20/2012 A Protein Unique to Prostate Cancer Has Been Identified | Protein may be used as a biomarker to distinguish indolent from lethal disease and serve as a novel drug target
- 6/20/2012 Prostate Cancer Cell Line Study Shows Potential New Route to Cancer Progression--SLC45A3-ELK4 Fusion | A study published in Cancer Discovery has identified an unusual pathway to prostate cancer progression.
- 6/5/2012 Denosumab Prolonging Bone-Metastasis Free Survival Featured at ASCO | The research team found that patients with shortened PSADT are at higher risk of developing bone metastasis, and denosumab is markedly effective at prolonging BMFS in the study's selected subset of patients.
- 6/5/2012 Radium-223 dichloride Proves Promising in Metastatic Prostate Cancer | The ALSYMPCA (Alpharadin in Symptomatic Prostate Cancer) trial used Radium-223 in treatment-resistant, metastatic prostate cancer patients and bone metastases.
- 6/5/2012 Investigational Drug OGX-247 Shows Patient Benefit in Phase II Clinical Trials | "We are encouraged by these early data that further support the ability of OGX-427 to suppress androgen receptor activity and tumor cell survival"
- 6/5/2012 RNA Prognostic Model Predicts Survival for Men with Prostate Cancer | Results found that the six-gene model suggests possible dysregulation in the system, which researchers believe requires further study.
- 6/4/2012 Moving Research and Management Forward For Men with Treatment-Resistant Metastatic Prostate Cancer | So, what's next? Presenters posed the question of what optimal sequences or therapies exist for men with treatment-resistant, metastatic prostate cancer?
- 6/4/2012 Phase I Clinical Trial Reveals Positive Immune Response in Cancers, Including Prostate | The Phase I clinical trial was conducted at five centers throughout the United States.
- 6/4/2012 Phase III Trial Results for Circulating Tumor Cell Counts and Overall Survival | Though researchers understand that CTC's are promising biomarkers in treatment-resistant, metastatic prostate cancer, it has not been validated for docetaxel treatment.
- 6/4/2012 Cancer Antigen MICA Plays Vital Role in Immune Surveillance | Immunotherapy research remains as a promising modality for the treatment of cancer, including prostate cancer—as well as an important tool in clarifying the mechanism of action for guiding patient selection.
- 6/4/2012 Phase III Study of Abiraterone Acetate in Metastatic Disease Presented at ASCO | Results from a Phase III clinical trial were presented at the annual American Society of Clinical Oncology (ASCO) meeting today.
- 6/3/2012 Practice Changing Data Results from 17 Year Study Presented at ASCO | Investigational researcher Maha Hussain, MD, FACP of the University of Michigan Comprehensive Cancer Center presented pivotal research at the 12th annual American Society of Clinical Oncology (ASCO) meeting.
- 6/3/2012 PROSTVAC Vaccine for Prostate Cancer to Enter Phase III Clinical Trials | PROSTVAC, a virus-based vaccine, successful showed an average 8.5 month overall survival benefit and favorable side effects in Phase II clinical trials
- 6/3/2012 Liver Metastases Help Predict Overall Survival in Metastatic Prostate Cancer Patients | A collaborative research team studied liver metastases in relation to overall survival in men with treatment-resistant metastatic prostate cancer (TRMPCa).
- 6/3/2012 PSA Decline Found in Phase I Clinical Trial Using KX2-391, Funding from PCCTC | The drug is potent against a broad range of solid tumor cell types, as well as many leukemia types, including those resistant to imatinib and/or dasatinib.
- 6/3/2012 Phase III Clinical Trial Compares Efficacy of Ipilimumab in Metastatic Prostate Cancer Patients | Ipilimumab is a fully human monoclonal antibody that augments antitumor response and is also responsible for blocking CTLA-4 (a protein that plays an important regulatory role in the immune system).
- 6/2/2012 Team of PCF-Funded Researchers Present MDV3100 Trial Results at ASCO | The clinical advancement of MDV3100 is one of the most important events in the history of prostate cancer research and the Prostate Cancer Foundation
- 6/2/2012 Testosterone Levels Studied in Neoadjuvant Trial | A team of prostate cancer researchers presented data during the annual ASCO conference on neoadjuvant (administration of therapeutic agents before a main treatment) androgen pathway suppression prior to prostatectomy.
May, 2012
- 5/31/2013 Funding from PCCTC Advances Study of Ketoconazole and Docetaxel Response Following Abiraterone Acetate | Ketoconazole (keto) is drug used in prostate cancer to block the release of testosterone from the adrenal glands, typically administered in conjunction with steroids to avoid side effects.
- 5/21/2012 Molecular Subtype of Prostate Cancer Discovered with Funding from PCF | Defect in SPOP gene found in up to 15 percent of all prostate tumors, aggressiveness yet to be determined
- 5/15/2012 DNA Biomarker Discovery Focuses on DNA Methylation | Published in Clinical Cancer Research today, Krishna Donkena, PhD and her research team at the Mayo Clinic found that DNA biomarkers produced by DNA methylation may be used to better detect prostate cancer recurrence and metastases.
April, 2012
- 4/23/2012 PCF-Funded Young Investigator, Dr. Tarek Bismar, Awarded Donald Coffey Prize for the Best Research Paper by BJUI | PCF-funded Young Investigator, Dr. Tarek Bismar, was awarded the Donald Coffey Prize for the best research paper of 2011, titled "PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer."
- 4/17/2012 Proton Therapy Update: No Evidence That Benefits Justify Cost | Dr. Matthew Cooperberg suggested that IMRT was associated with better results in the article, though it did cause more erectile dysfunction than 3D conformal radiation.
- 4/17/2012 HIFU Technology Progresses, More Clinical Research Is Needed | A recent study conducted at the University College London shows that HIFU may offer the promise of effective ablation in low-grade lesions, if all cancer cells can be reached.
- 4/9/2012 Prostate and Breast Cancer Vaccine Progressing | The progress of vaccines continue to progress and PCF is pleased to see a growing interest in the field.
- 4/5/2012 PCF Researcher Dr. Carl June Presents Results on "Performance Enhanced" T-Cell Therapy in Leukemia | Dr. June described a therapeutic method that successfully used a patient's own lymphocytes to treat a type of leukemia.
- 4/5/2012 Dr. Karen Knudsen Identifies "Next Generation" Gene Targets for Prostate Cancer | Karen Knudsen, PhD participated in a session at the AACR conference focused on identifying the next generation of gene targets for prostate cancer.
- 4/5/2012 PCF Scientific Advisory Board Member Martin G. Pomper Speaks on Molecular Imagining and Theranostics | Dr. Martin G. Pomper, reported on the increased need for studies of the genetic and molecular basis of cancer, including the use of molecular imaging for the use of noninvasive analysis of cancer biology in vivo.
- 4/4/2012Dr. Charles Sawyers Discusses the Coming of Age in Pathway-Targeted Therapeutics, MDV3100 | During a plenary session at the AACR conference, panel speakers discussed therapies targeting oncogenic signaling pathways and their continued maturity within the field of cancer research.
- 4/4/2012 Data Presented by Dr. Sarah Nechuta on the Role of Cruciferous Vegetables and Sulphorophane in Broccoli | Over the past 19 years, PCF funding has stimulated some of the most rigorous nutrition and diet research of any cancer research funding agency.
- 4/4/2012 Correlation Between Excess Body Weight and Prostate Cancer Identified by Dr. Vincent Freeman | Endpoint results showed that the risk for cancer recurrence increased with increasing BMI
- 4/4/2012 First Prostate Nanomedicine Shows Positive Results in Phase I Trials | This research represents the first time a nanomedicine has moved from the test tube to the clinic to target prostate cancer cells effectively and to deliver docetaxel in high concentrations safely.
- 4/4/2012 PCF-Supported Researcher Dr. Chuck Ryan Focuses on New Prostate Cancer Drugs | Dr. Charles Ryan presented data results on agents used in the treatment of prostate and genitourinary cancers at the 103rd annual AACR conference.
- 4/3/2012 PCF-Funded Investigator Presents on Investigational Drug Galeterone | Galeterone showed great than 30% PSA reduction in all patients with some patients demonstrating 90% PSA declines.
- 4/3/2012 Dr. Gulley, PCF-Supported Scientist, Discusses Differences in Targeted and Immune Therapies | PCF-supported researcher Dr. James Gulley presented data results during the plenary session at the AACR conference today.
- 4/3/2012 PCF-Funded Young Investigator Presents Research on Imaging Androgen Receptor Signaling | Dr. Ulmert and his research teams' work are focused on the development of radiotracers to detect cancers or monitor treatment responses, with specific attention to clearer usage in the clinic.
- 4/3/2012 Bringing Next-Generation Sequencing to the Cancer Clinic for Precision Medicine | Recent advances in next generation sequencing afford new opportunities to uncover specific genetic mutations that drive cancers.
- 4/2/2012 PCF-Funded Researcher Presents Data on Chromatin States Found In Stem Cells | Dr. De Marzo at Johns Hopkins Department of Pathology and graduate student colleague Laxmi Pellakuru presented a poster session focused on understanding how molecular mechanisms are responsible for altering chromatin states in stem cells and cancer cells.
- 4/2/2012 PCF Partner Institutions Honored at AACR Opening Ceremony | The opening ceremony at the American Association of Cancer Research (AACR) conference awarded two PCF-supported institutions, the Institute of Cancer Research (ICR) and the Royal Marsden Hospital, with the AACR Team Science Award.
- 4/2/2012 PCF Award Recipient Steven Balk Chairs Session on Advances in Androgen Receptor Discovery | Prostate Cancer Foundation Challenge Award recipient, Steven P. Balk at Beth Israel Deaconess Medical Center in Boston, MA chaired a session focused on recent advances made in targeting androgen receptors for prostate cancer prevention and therapy.
- 4/1/2012 PCF-Funded Scientists Say Diabetes Medication Shows Promise Against Cancers, Including Prostate | Data presented at the annual AACR meeting on metformin showed promising results against a variety of different cancers, including prostate cancer
- 4/1/2012 Robotic High-Throughput Screen Featured at AACR | William Sellers, Vice President of Oncology at Novartis Institutes of Biomedical Research, featured the development of a robotic high-throughput screen that allows testing 1,300 drugs on 70 different cancer cell lines, while at the same time, generates 27 million data points.
- 4/1/2012 PCF Support Facilitates AACR Recognition Awards | During the American Association for Cancer Research (AACR) annual meeting, titled "Accelerating Science: Concept to Clinic," three Prostate Cancer Foundation supported researchers were recognized for their early-career efforts in the field of prostate cancer research.
March, 2012
- 3/23/2012 Dr. Ballentine Carter Elected Trustee of the American Board of Urology | Dr. Ballentine Carter, a Prostate Cancer Foundation (PCF) funded researcher, mentor and sterling clinician, was elected Trustee of the American Board of Urology (ABU), beginning his six-year term on February 28, 2012.
- 3/23/2012 Dr. Charles Sawyers Elected AACR President | "Dr. Sawyers is an outstanding leader and mentor of young scientists in the field of cancer research"
- 3/22/2012 Scientists Identify New Mechanism of Prostate Cancer Cell Metabolism | Dr. Charles Sawyers, Prostate Cancer Foundation funded researcher since 1996, supporter and long-time friend, was named president-elect of the American Association for Cancer Research (AACR) and will begin his term in April 2013.
- 3/14/2012 Dr. Patrick Walsh, Renowned Prostate Cancer Researcher, Receives the Amory Prize | Patrick Walsh, MD, of Johns Hopkins University School of Medicine, today received the prestigious Amory Prize award from the American Academy of Arts and Sciences.
- 3/12/2012 PCF Initiates China Research Program | The Prostate Cancer Foundation (PCF) launched a new research initiative in China, partnering with the Chinese Urological Association, in an effort to promote and fund prostate cancer research.
- 3/9/2012 Novel Therapy Zytiga Approved by FDA for Metastatic Prostate Cancer | Zytiga® (abiraterone acetate) was approved by the US Food and Drug Administration in April 2011 for the treatment of metastatic castration-resistant prostate cancer (mCRPC), following docetaxel chemotherapy.
- 3/9/2012 PCF Announces Winners of Young Investigator Award in China | The Prostate Cancer Foundation announced its first two Young Investigators in China to launch its initiative to identify, fund and promote innovative research projects within China.
- 3/8/2012 China on Front Lines of Fight Against Prostate Cancer | How does the body of a Chinese farmer differ from that of his African-American counterpart?
February, 2012
- 2/27/2012 A Driver of Prostate Cancer Progression Identified by Two PCF-Funded Researchers | The article below was funded by two PCF Competitive Awards (valued at $100,000 each)
- 2/27/2012 Cancer Discovery Shows Promise of New Drugs | Researchers at the University of California, San Francisco discovered how a protein can go awry, leading to prostate cancer metastasis.
- 2/24/2012 Active Biotech and Ipsen report for the first time Tasquinimod (TASQ) phase II long term safety data | Active Biotech's (NASDAQ OMX NORDIC: ACTI) and Ipsen's castrate resistant prostate cancer project, TASQ will be presented at the 27th Annual EAU Congress held in Paris on 24-28 February 2012.
- 2/13/2012 Nerve Sparing Study Plays Important Role in Sexual Function | The vast majority of men who have a prostate cancer operation can retain their ability to orgasm if the surgery is carried out without removing the nerves that surround the prostate gland like a hammock, according to a study in the February issue of the urology journal BJUI.
- 2/10/2012 Mentorship and Data Exchange Expand Prostate Cancer Research | Researchers at Thomas Jefferson University are investigating the role of curcumin (a spice originating in India) and its role in slowing prostate cancer tumor growth.
- 2/9/2012 Heart Disease May Be a Risk Factor for Prostate Cancer | In a large analysis of men participating in a prostate drug trial, researchers at the Duke Cancer Institute found a significant correlation between coronary artery disease and prostate cancer, suggesting the two conditions may have shared causes.
- 2/9/2012 Brachytherapy Can Be Successful for High-Risk Prostate Cases, Too | Although brachytherapy has not been considered a highly effective form of treatment for high-risk prostate cancer, it was shown to reduce prostate cancer–specific mortality (PCSM) compared with external beam radiation therapy (EBRT) alone in a recent large analysis.
- 2/8/2012 ProstaCaid™ Inhibits Tumor Growth in a Xenograft Model of Human Prostate Cancer [JOURNAL] | We have recently demonstrated that the dietary supplement ProstaCaid™ (PC) inhibits growth and invasive behavior of PC-3 human prostate cancer cells in vitro.
- 2/8/2012 Third Peer-Reviewed Study Proves Botanical Formula Fights Prostate Cancer Without Toxicity | Scientists at Indiana University, Methodist Research Institute, study a botanical formula that kills aggressive prostate cancer tumors
- 2/7/2012 Urine Test Could Supplement Prostate Cancer Biopsy | PCF funding continues to advance early diagnostics
- 2/7/2012 Fast Track Treatment Continues to Make Progress | On June 6, 2011, the Prostate Cancer Foundation reported promising Phase III clinical trial results for Radium-223 (Alpharadin) that were presented at the annual American Society of Clinical Oncology meeting in Chicago.
- 2/2/2011 OGX-427 Used with Prednisone Shows Promising Results for Prostate Cancer Patients | A panel of PCF-Safeway funded Canadian and U.S. researchers presented data from a Phase II clinical trial using OGX-427 in combination with prednisone versus prednisone alone at the 2012 ASCO Genitourinary meeting this week in San Francisco.
- 2/2/2012 Promising New Therapeutic Targets Bone and Disperses Radiation | Alpharadin may decreases bone metastases and reduce death
- 2/1/2012 Researchers' Work in Prostate Cancer and Exercise Advances | June Chan focuses on early-stage disease
January, 2012
- 1/27/2012 PCF Lays the Foundation for Roswell Park Vaccine Trial | Prostate Cancer Foundation funding to Drs. Jim Allison and Padmanee Sharma (who studied NY-ESO-1 and other tumor antigens for chemotherapy) provided a foundation for a research breakthrough made at Roswell Park Cancer Center.
- 1/11/2012 A Model For Life Sciences Research Funding | Ever wonder where the money goes when you donate to a large "Fight This Cancer" campaign?
- 1/5/2012 Energy and Advocacy Preserve Crucial PCa Research Funds | With efforts from the Prostate Cancer Foundation and the U.S. prostate cancer advocacy community, led by the Prostate Cancer Roundtable, the 2012 budget for Congressionally Directed Medical Research Programs was preserved.
November, 2011
- 11/3/2011 PCF Funding Leads to MDV3100 Clinical Successes | All trial participants receive drug, not placebo.
- 11/1/2011 Dr. Oliver Sartor on Radium-223 at 2011 PCF Scientific Retreat | Dr. Oliver Sartor, a member of the PCF Research Community, was the principal investigator for the study sites in the United States.
- 11/1/2011 AgonOx Partners with MedImmune for Development of OX40 Agonists in Cancer Therapy | PCF-funded researchers partner with AgonOx Partners and MedImmune to develop tumor-specific agonist.
September, 2011
- 9/27/2011 U.S. Scientists Map Genome of Advanced Prostate Cancer | Researchers discover genetic 'hypermutations' that help tumors resist common therapies
- 9/19/2011 FDA Expands Approval for Denosumab | On Friday, September 16, 2011, the Food and Drug Administration (FDA) approved denosumab (Prolia) to increase bone mass in non-metastatic prostate cancer patients undergoing androgen deprivation therapy (ADT).
- 9/7/2011 Abiraterone (Zytiga) Approved in European Union | Today's approval of Abiraterone (Zytiga) in the European Union (EU) offers a new treatment option for more than 70,000 patients living with prostate cancer in European member states.
August, 2011
- 8/23/2011 FDA to Decide by April 26 on New Xgeva Application| Prevention of metastases represents promising new use for Xgeva
- 8/23/2011 FDA Grants Fast Track Designation to Radium-223 Chloride for the Treatment of Castration-Resistant Prostate Cancer That Has Spread to the Bone| Decision may make new treatment available for patients faster
- 8/22/2011 5-Gene Signature Identifies Lethal Varieties of Prostate Cancer and May Better Direct Patients to Appropriate Levels of Treatment | Discovery enabled by collaborative effort of scientists at more than a dozen institutes in U.S. and Sweden
July, 2011
- 7/29/2011 UT Southwestern PCF Young Investigator Identifies New Pathway Explaining Resistance to Prostate Cancer Treatment | Discovery Opens Door to New Target for Drug Development
- 7/28/2011 Abiraterone (Zytiga) Approved in Canada | Janssen Inc. announced today that after a priority review, Health Canada has approved ZYTIGA™ (abiraterone acetate), the oral medication for the treatment of men with metastatic prostate cancer.
- 7/27/2011 Intermittent Androgen Deprivation | Changing the standard of care for men with recurrent prostate cancer
- 7/25/2011 Final European Approval of Abiraterone (Zytiga) Expected Within Weeks | Approval will open new treatment option for more than 70,000 patients each year in the EU
- 7/6/2011 Stearns' Amendment to Increase Prostate Cancer Research under Department of Defense Gets Bipartisan Approval | $16 Million Increase in Prostate Cancer Research Adopted by Voice Vote
June, 2011
- 6/27/2011 Duke Team Finds New Clues to How Cancer Spreads | PCF-funded investigator lead author of the study
- 6/6/2011 News from ASCO: Alpharadin Significantly Improves Overall Survival in Phase III Trial in Patients | Good news for patients with castration-resistant prostate cancer that has spread to the bone
May, 2011
- 5/30/2011 Medicare Moves to Pay for Prostate Cancer Drug Provenge | This is encouraging news for many prostate cancer patients with advanced metastatic disease who may benefit from treatment with Provenge.
- 5/23/2011 Half of Prostate Cancers Could Potentially Benefit From New Type of Cancer Drugs | Work was a team effort led by PCF-funded investigator Dr. Arul Chinnaiyan
April, 2011
- 4/19/2011 KRAS Gene Fusion in Prostate Cancer | This recently published study suggests that rare gene fusions or rearrangements of a gene called KRAS, may be associated with more aggressive metastatic prostate cancers and tumor progression.
March, 2011
- 3/25/2011 FDA Approves Drug Found to Prolong Lives of Melanoma Patients | Today's FDA approval of ipilimumab for the treatment of malignant melanoma is the second immunotherapy approved for the treatment of cancer.
- 3/24/2011 Prostate Cancer Spreads to Bones by Overtaking the Home of Blood Stem Cells | Like bad neighbors who decide to go wreck another community, prostate and breast cancer usually recur in the bone, according to a new University of Michigan study.
- 3/7/2011 UCLA Researchers Use 'Nano-Velcro' Technology to Improve Capture of Circulating Cancer Cells | New method may help improve diagnosis and treatment-monitoring of cancer
- 3/2/2011 Scientists Target Aggressive Prostate Cancer | SPINK1 gene could be to prostate cancer what HER2 has become for breast cancer
Febraury, 2011
- 2/9/2011 First Look at Prostate Cancer Genome Yields Insights | Newly detected DNA changes may eventually lead to better treatments
January, 2011
- 1/4/2011 PCF $3 Million Investment in Circulating Tumor Cells Delivers Ten‐Fold Investment by Johnson & Johnson within Three Years | Circulating tumor cells (CTCs), found in patients' bloodstreams, are shed from tumors and may be responsible for metastases.
December, 2010
- 12/3/2010 Scientists Find Protein That May Help Control Prostate Cancer | Discovery could aid in limiting tumor growth and progression, expert says
October, 2010
- 10/11/2010 Abiraterone Offers Hope in Advanced Prostate Cancer | Drug may reach market next year
July, 2010
- 7/20/2010 FDA Grants Denosumab Priority Review for Cancer-Related Bone Loss | The FDA has granted denosumab priority review for treatment of bone loss and fractures in patients with advanced prostate cancer.
June, 2010
- 6/17/2010 Cabazitaxel (Jevtana) Approved for Advanced Prostate Cancer | When disease continues to worsen after treatment with standard drug
April, 2010
- 4/29/2010 Prostate Cancer Vaccine Gains FDA Approval | The History of Provenge
September, 2015
July, 2015
June, 2015
May, 2015
April, 2015
March, 2015
February, 2015
January, 2015
September, 2014
Print |


text:
A series of weak data points on Thursday gave investors renewed confidence the Federal Reserve likely won't raise interest rates until the year's end at the earliest.
Stocks add to gains on Thursday after weak U.S. economic data undercuts the chances of a rate hike when the Federal Reserve meets next week.
Shares of V.F. Corporation were lower Thursday after Bank of America/Merrill Lynch downgraded the stock
BofA/Merrill Lynch cut VF Corp's (VFC) stock rating to 'underperform' this morning.


text:
No Limits, Just Messy Madness: An Inside Look at Every Child's Dream Art Studio
What do you get when you convert a salad bar into an art studio? Art ala Carte. In this colorful, comfortable studio, kids can channel their inner creativity for hours on end and can craft whatever they dream up. From birdhouses to spaceships, picture frames to abstract art, Aria Leighty's Portland-based studio provides her local community with a fun place for self-expression.
Early in her career while working at the YMCA, Aria noticed that there was a huge opportunity to improve children's art programming. Determined to empower kids to shake off creative boundaries and time limits, she mused that it would be fun if there were salad bars that kids could visit and load up trays of limitless supplies. In 2012, Art ala Carte, a minority-owned, woman-owned, and mommy-owned business was born and Aria made her vision a reality.
In addition to her open studio, Aria's two most popular events include Messy Madness and Parent's Night Out. During Messy Madness, kids up to 3 years old can experience a 'one of a kind play date,' where they can get messy on huge canvases with finger paints, painting their toes and fingers into a work of art. Equally adorable is Aria's Parent's Night Out, during which parents can drop off their kids for 3 hours at the studio while they can get some all-too-necessary time to themselves.
When asked what Aria loves about planning events, she replied, "I don't love anything about planning events. It's a stressful process, but thankfully Eventbrite has alleviated some of that stress." Eventbrite has even helped her find new customers, as she explains that she frequently sees new names of people registering for events.
Before using Eventbrite, Aria was just having people email her to sign up for her popular events, which became too much for her to manage. After a friend told her about Eventbrite, she made the switch. "I feel like it is so much easier to manage and reply to emails. Having all of the payment information right there is just so convenient for me," she says.
So, what's next for Art ala Carte? Aria wants to ramp up mobile events, setting up locations across the city in libraries and malls. No matter what's next on the horizon for Aria, one thing's for sure: Art ala Carte makes every grown-up secretly wish they were a kid, because what's better than a little messy madness?


text:
School Gardens: Benefits and Sustainability in Rural NL
Lead Researcher and Department
Emily Doyle, Community Health and Humanities
Collaborators and Students
Dr. Martha- Traverso Yepez
Funding Resources
Harris Centre Strategic Partnership Research Fund
I will develop a pilot study at St. Francis School in Harbour Grace, which is one of the few school gardens in NL. The St. Francis school greenhouse program is a unique example of innovation in the province with regards to health, the environment, agriculture, and education. The pilot study will include key informant interviews with parents, teachers, and community leaders involved or interested in the project. The goal of the interviews is: to investigate the start and evolution of the program; analyze facilitators and deterrents for keeping the program running; identify benefits of the program; and become familiar with key aspects to maintain sustainability.
January 2013/ January 2014
school garden newfoundland
Newfoundland and Labrador, Canada
Industry Sectors
Agriculture, forestry, fishing and hunting
Educational services
Thematic Categories


text:
CBD Releases Second National Reports on Biosafety, Launches Report Analysis Tool
30 November 2011: The Secretariat of the Convention on Biological Diversity (CBD) has made available on its website the second national reports on implementation of the Cartagena Protocol on Biosafety. It also launched an interactive tool for information search and analysis of the reports.
According to the CBD notification, the Secretariat has received 124 reports to date, which are made available through the "Finding Information" section of the Biosafety Clearing House (BCH). This tool allows for the analysis of the reports by country or geographical region, as well by questions or report sections. [CBD Notification] [National Reports Website]


text:
For more than a decade, U.S. service members have been going to combat zones in the Middle East, where they become targets for bullets and roadside bombs.
When the wounded ones come home, they go to VA hospitals to learn how to avoid hazards like falling down steps.
The irony isn't lost on them, said Dr. Frederick Struthers, the Van Zandt VA Medical Center's chief of physical and rehabilitative medicine, at a ceremonial opening Wednesday for a $3.6 million, 8,500-square-foot addition to house his department.
Article Photos
Mirror photo by Patrick Waksmunski
James E. Van Zandt VA Medical Center occupational therapist Jamie Oravec (right) shows outpatient dietician Steve Beschler a new total body recumbent stepper during open house of the new physical, occupational and speech therapy building Wednesday. The center opened a $3.6 million addition Wednesday.
Mirror photo by Patrick Waksmunski
James E. Van Zandt VA Medical Center physical, occupational and speech therapy supervisor Tim Skarada demonstrates the new variable-speed underwater treadmill for aquatic therapy to Barbara Babiak of the Health Education Management department.
"They'll say, 'This is crazy,'" said Struthers, standing near an accessible kitchen, bath and bedroom, where vets relearn household tasks under the watchword "safety." "'[They'll say] I was over there and people were shooting at me.'"
The new facility, plus a similar-sized, $2.5 million addition for department offices currently under construction next door, will enable Struthers' 18-member staff to help wounded vets make the transition better, Struthers and hospital spokeswoman Andrea Young said.
The old department on the second floor was only a quarter as big with fewer rooms and less equipment, they said.
Yet it hosted 15,000 visits last year.
The new facility should be even busier, as the hospital expects an annual 20 percent growth in the rehab patient count.
But the new one offers much more privacy, weight machines that are adaptable for wheelchairs, room for group work that encourages compliance with exercise routines, a sling on an overhead track to support unsteady walkers and an underwater treadmill for low-impact, high resistance workouts.
Still, even with the newest facilities, transition from combat to civilian life isn't easy for the wounded.
In war zones, service members were macho men with big weapons, Struthers said.
Back home, they struggle with ordinary tasks.
Many have a hard time admitting they need help, Struthers said.
Some can't commit to their own rehabilitation, because of guilt - maybe for failing to save a buddy - and others can't commit because of rage at those who killed that buddy.
Many struggle to get over their difficulties because they can't express their troubling thoughts, believing that to do so would make them seem "horrible," he said.
It helps to have staffers with combat experience, because they can understand without having to probe too much, Struthers said.
The staff has several such combat veterans, including Struthers himself, who fought in Vietnam.
Veterans who must relearn household tasks - because of fresh combat wounds, deficits from old wounds that surface due to age or injuries or illnesses - benefit from close analyses of actions that the rest of us take for granted, Struthers said.
Staffers work with those patients to pre-plan how to get into the bathtub, for example - sitting down on a special seat at first, shifting one leg over the edge and perhaps lifting the other with a special device, he said.
The staffers also work with wives, friends and children of veterans, teaching them how to help.
They require a higher level of accomplishment for veterans who live alone.
The "safety" mantra in the physical and occupational rehabilitation department under Struthers may be ironic to those who have served in acute danger.
But the wounded returnees also find it therapeutic, the doctor agreed.
"They [know] we care about them," he said.
Mirror Staff Writer William Kibler is at 949-7038.


text:
Oscar Pistorius
1,988pages on
this wiki
this wiki
Oscar Leonar Carl Pistorius is an active South African Sprint Runner. He is an Amputee on both legs and runs on blades. He holds the record for the T44 400m sprint. He is well known for running in the Olympics and Paralympics.


text:
Madison man arrested for refusing to pull up pants
Incident Type Disturbance Incident Date 02/07/2014 - 9:00 PM Address 89 East Towne Mall Arrested Steven L Price, Male, Madison: Resisting and Disorderly Conduct Details On 2/7/14 at approximately 9 p.m. several Madison Police Officers responded to 89 East Towne Mall for a disturbance. It was learned that Price was the cause of this disturbance. Price was warned by mall security that he needed to walk with his pants pulled up, as his underwear was clearly exposed. The mall's policy is for people to walk with pants in such a manner where underwear is not exposed to other patrons. Price refused to follow the basic rules. Price was removed from mall and returned. As mall security detained Price, he became agitated and more resources were needed. As Madison Police Officers arrived and tried to remove Price, he resisted and caused a disturbance instead of complying with lawful orders. Price was arrested and transported to the Dane County Jail.


text:
NEW YORK — Joe Johnson scored 21 points, Marcus Thornton came off the bench for 20, and the Brooklyn Nets powered their way above .500 for the first time this season by beating the Memphis Grizzlies 103-94 on Wednesday night.
Deron Williams added 16 points and Paul Pierce 14 for the Nets (30-29), who have won four in a row overall and six straight at home in turning around a turbulent start.
They are still only sixth in the Eastern Conference, but look capable of climbing more after following a rout of Chicago on Monday by clobbering the Grizzlies for most of this one.
The matchup between two of the NBA's best teams in 2014 was a mismatch until the fourth quarter, when the Nets had already led by 30. Memphis fell to 21-9 since Jan. 1, while the Nets' 20-8 record is tops among East teams.
Jason Collins played 17 scoreless minutes on the day he signed his second 10-day contract. The NBA's first openly gay player got a visit in the locker room before the game from Commissioner Adam Silver, but received just polite applause when he checked in during the second quarter after getting a standing ovation Monday during his home debut.
Pierce went right at Randolph's replacement, Ed Davis, and already had eight points by the time Davis was yanked with the Grizzlies trailing 13-2. James Johnson replaced him and quickly botched a fast-break layup as Memphis missed 10 of its first 11 shots. Andray Blatche's three-point play made it 26-5 with 3:30 left in the first, and Brooklyn led 54-44 at halftime.
Brooklyn scored the first 11 of the second half to open a 19-point lead and kept pouring it on by making six 3-pointers in the third quarter. The lead hit 87-57 on Johnson's short jumper, but the Nets had to bring starters back when the Grizzlies sliced that in half by midway in the fourth.
The Nets were 10-21 after getting blown out at San Antonio on New Year's Eve, threatening to become the NBA's biggest flop after building a team that would cost more than $180 million in salary and taxes.
But they've kept rolling after losing leading scorer Brook Lopez for the season, and most recently playing without Kevin Garnett for the past three because of back spasms.
They picked up Thornton in a trade with Sacramento just before the trade deadline, a move that was all but ignored after they signed Collins a few days later. But he's scored 20 or more in two of his first five games with the Nets, and had 15 in the second quarter alone Wednesday.


text:
PLUS Media
20 West 23rd Street
New York, NY 10010
Tel: (212) 206-8160
Fax: (212) 206-8168
firstname.lastname@example.com, firstname.lastname@example.com
Natalie Weissman, Andrea Goldberg
email@example.com, email@example.com
Tel: (212) 206-8160
Company of the Week
SK&A is a leading provider of U.S. healthcare information solutions and databases. As part of IMS Health, SK&A researches and maintains contact and profiling data for over 2 million healthcare providers, including 800,000+ prescribers. SK&A's data supports research and marketing initiatives for life sciences, medical device, managed healthcare, direct marketing, publishing, education and more. SK&A's proprietary databases are telephone-verified twice per year from its world class Research Centers. SK&A enables multi-channel marketing and sets the standard for data quality and reliability. SK&A's customers include many of America's most recognized healthcare, publishing and pharmaceutical institutions.


text:
Some of the league's top rookies—Kyrie Irving, Klay Thompson, Ricky Rubio—will not be making their first playoff appearances in 2012.
However, there are a handful of rooks who will take center stage in the 2012 playoffs. And not only will they take center stage, but they also have the opportunity to play pivotal roles for their respective clubs.
Some of these rookies could even become the "X-factors" that spark their teams to deep playoff runs, and perhaps even a championship.
Here are the top rookies to watch throughout the 2012 playoffs.
(Note: New York guard Iman Shumpert would've surely been on this list, but he will no longer be a factor. He tore his ACL in Game 1 against the Miami Heat.)


text:
Erin Michele Sauers and Thomas Louis Paternostro Jr., both of Mifflinburg, were united in marriage at 3 p.m. Saturday, April 2, 2011.
The Rev. Steve Stoltzfus officiated at the ceremony held at Freedom Fellowship Church, Mifflinburg, where a rehearsal dinner was held.
A reception was held at Tedd's on the Hill, Shamokin Dam.
Article Photos
(Erin Michele Sauers)
The bride is the daughter of Joanne and Dennis Sauers, Mifflinburg. She graduated from Mifflinburg High School in 2001 and received a bachelor's degree from Susquehanna University, Selinsgrove, in 2005. She is employed as a protective service worker at Union-Snyder Agency on the Aging Inc., Lewisburg.
Paternostro is the son of Cynthia and Thomas Paternostro, South Williamsport, and Steven and Elizabeth Bower, Mifflinburg. He graduated from Mifflinburg High School in 2001 and SUN Tech, New Berlin. He is employed by Pik Rite Inc., Lewisburg.
Matrons of honor were Christy Sauers, Harrisburg, and Erin Sauers, Mifflinburg, sisters-in-law of the bride.
Bridesmaid was Nicole Paternostro, South Williamsport, sister of the bridegroom.
Flower girl was Mackenzie Richard, Mifflinburg, cousin of the bride.
Ring bearer was Dax Sauers, Harrisburg, and Logan Sauers, Mifflinburg, nephews of the bride.
Best man was Jason Sauers, Mifflinburg, brother of the bride.
Groomsmen were Michael Berge, Lewisburg, and Kent Bower, Mifflinburg, brother of the bridegroom.
Following a trip to Foxboro Bed and Breakfast, Selinsgrove, the couple is residing in Mifflinburg.


text:
North Charleston would stop denying taxi licenses to those with drug possession convictions that are more than two years old, under a plan City Council unanimously endorsed Thursday.
While one more vote at a future meeting would be required to change the city's taxi ordinance, no member of City Council has opposed the plan.
Currently, anyone with a drug possession conviction within the past five years, for any drug except marijuana, cannot get a taxi license in North Charleston. Marijuana possession convictions within the past year are also grounds for denial.
The proposed changes, which also adjust some fees and inspection regulations, would cut the look-back period for past drug use to two years, while keeping the one-year rule for marijuana.
"We opened it up so that more people can become taxi drivers," Councilman Michael Brown said at a meeting Thursday night.
The current rule on prior drug use is the same standard used for police officers, according to city officials.
"We gave (the regulations) some time to see what works, what didn't and what we needed to be a little more flexible with," said Julie Elmore, special assistant to Mayor Keith Summey, earlier this week.
The current taxi regulations came from a 2009 effort to address what the city said were complaints about dirty and poorly maintained cabs, taxi drivers who overcharged out-of-town visitors, and even cabs being used to facilitate criminal activity.
The following year drivers complained that they were being repeatedly stopped and fined $500 for minor infractions, such as having a messy car. The city later reduced the fine for violations from $500 to $100, and eased restrictions about prior DUI convictions.
On Thursday Councilwoman Dot Williams told Mayor Keith Summey that the city's current taxi inspector, Patrick Pontieri, is doing a good job.
"I have not heard one complaint since you put him on board," she said.
Reach David Slade at 937-5552 or Twitter @DSladeNews.


text:
Mother's Day is nearly upon us. As I scramble to come up with a halfway decent gift (remember when we could get away with handmade cards and coupons for hugs?), I keep thinking about how much my mom has shaped my food philosophy and nurtured my love of cooking. So I thought I'd share a few of the lessons I've learned about food, cooking and life from my mom, Madeline.
- Cooking dinner for people means you get to be the first one to have wine.
- Don't fear any recipe/dish/ingredient. The worst thing that will happen is you fail, which isn't so bad because you can always just make eggs or order pizza.
- Don't waste food. Even leftovers. Even if you don't like eating leftovers. Same goes for withered lettuce (pick it out!), moldy cheese (cut it off!) and expired milk (smell it first!).
- Restaurants are great because you don't have to clean the dishes.
- Cheese omelets are just as good for dinner as they are for breakfast.
- Eat fresh fruit and vegetables every single day. No matter what.
- Don't overcook fish! (She's from the East Coast.)
- If someone at your table doesn't ask for seconds, they probably didn't like the food.
- If you can make a whole meal in one pot, you've succeeded.
- Food is love. You should say this one aloud every day, because it's absolutely true.
Love you, Mama. Thanks for making me want to be a cook. (And yes, you're still getting a real gift on Sunday.)


text:
Baseball 2015 Release Schedule
We will begin taking orders for the season disk starting after the World Series. We will begin shipping after Thanksgiving.
We will begin shipping the card set in January. The start date for orders will be after we ship the season disk.
The Next Generation of APBA
For 60 years APBA has been the unchallenged King of quality sports strategy games.
Get in on the excitement with the fun, quick, and easy way to play your favorite sports, APBA Games! APBA puts you right in the middle of the action and allows you to enjoy th


text:
- Patt Morrison Radio Show: Making Teachers More Valued
On March 17, Deborah Ball guested on Patt Morrison, a radio show that airs for two hours every day on NPR affiliate Southern California Public Radio. The March 17 episode focused on the recently released Program for International Student Assessment (PISA) report, which compares education systems in more than 50 countries and recommends that the U.S. education system shift its focus - and funding - toward recruiting, training and retaining teachers. As a featured guest, Ball discussed teacher status, class size, and education funding, emphasizing that effective teacher preparation is the most powerful lever the U.S. has for improving K-12 education. She also responded to listeners' call-in questions.
go to the Southern California Public Radio site to listen to Ball's segment »


text:
Looks like Parke East Apartments is no longer available on Rent.com which means this information is likely out of date.
Make sure to check out these similar properties in the area.
Contact for details
If comfort and convenience are important to you, make Parke East Apartments your new home. Sprawling oaks and a serene setting with a convenient commute to the airport, work and shopping.
Million Dollar Community Renovations In Progress! Parke East features beautiful luxury apartments in Southeast Orlando, Florida. Residents looking to relocate to the affluent Southeast Orlando area can choose from a variety of one, two and three bedroom rentals to call home. Our residents love the modern look of decorative vertical blinds, a full appliance package and a brand new washer & dryer in every Orlando rental home. Enjoy coming home to your own, beautifully crafted energy-efficient kitchen with a stylish breakfast bar for easy entertaining.
At our luxury Orlando apartments homes, you will enjoy world-class amenities such as screened-in balconies and modern, colorful architecture. At Parke East, we know the details matter, and we provide a car care center for your convenience. Schedule a tour today to discover what makes Parke East the best apartments in Orlando, FL.
Our professional staff prides itself on finding you the right Southeast Orlando apartment. With many resources, and weekend hours to cater to your busy schedule, our friendly staff are eager to assist you. If you would like more information about the Parke East Apartments, contact us today.
Online payments available plus we accept Master Card, Visa and Discover cards. Lease Terms: 7-13 months. Security Deposit: $100 (with favorable credit score). Pet Policy: 2 pets maximum. Breed restrictions: $300 for one pet or $400 for two pets (non-refundable), pet rent is $10 per month, per pet.
Lease Terms: 7-15 months. Security Deposit: $100 (with favorable credit score). Pet Policy: 2 pets maximum. Breed restrictions: pitbulls, rotweilers, dobermans, chows, akitas, huskies, staffordshires and german shepards. Non-refundable Pet Fee of $300 up to 35 lbs or $400 for larger pets, pet rent is $15 per month, per pet.
Call for Policy. Cats Allowed. Dogs Allowed. Call for service animal policy.
272 units
Don't have a Rent.com account? Create one.
Creating an account allows you to acccess your saved and contacted properties on any device. Already have an account?
Log In
We are experiencing technical difficulties at the moment. Please try again later.


text:
^ Lighting
Narrow your search for
Wall Sconces...
Wall Sconces...
External Ads:
Open Box Deals
Up to 80% Off
10% Off Most Items*
Top Wall Sconces
Shop by Width: 4" 6" 8" 10" 12" 14" 16" 18" 20" 24" Height: 12"-13" Show All Heights
$180.00 $269.99 In Stock
Elk Lighting 9"w Dimensions Tiffany 2-Light Wall Sconce Burnished Copper 700442
$198.00 $329.99 Custom Made
Meyda Tiffany 6"w Cylinder 1-Light Wall Sconce Black in White Blanco Swirl 68815
Still searching for Wall Sconces?
Live Chat with an Expert and we'll be happy to help you search.
Or try expanding your selection in Wall Lights...
Type: Show more than just wall sconces
Type: Show more than just wall sconces
Also see related categories below, or view our Full Site Map
Did you see these other categories in Wall Lights?
Also try these nearby departments


text:
New subscription
Renew my subscription
Give a gift
Pay my bill
Change my address
Jesus Is Lord ! (china & wild cat in picture)
Active within 978 Days
Hi! My name is Jesus Is Lord ! (china & wild cat in picture)
I am Domestic Mediumhair from Hohenwald, TN
Nicknames: Life and Death. "For the wages of sin is death, but the gift of God is eternal life in Christ Jesus our Lord." -Romans 6:23
Age: 8 years old
Gender: F
Coat: short haired
Education: Christians should be known for love. (2 John 5)
My favorite tricks and treats are: Repentance is essential for the Holy Spirit to work. (Acts 2:38) and "Hatred stirs up strife, but love covers all sins." -Proverbs 10:12
Where I hang out: Definiton of faith: "Now faith is the substance of things hoped for, and the evidence of things not seen." -Hebrews 11:1
My favorite grubs: Who can be saved? "And it shall come to pass that whosoever calls on the name of the Lord shall be saved." -Joel 2:32
My pet peeves: Avoid making enemies. "He who covers a trangression seeks love, but he who repeats a matter seperates friends." -Proverbs 17:9
What I love about my owners: THE BEATITUDES. Read Matthew 5:1-12.
My cat hobbies: THE TRUE VINE. Read John 15:1-17.
Pet motto: THE TEN COMMANDMENTS- Exodus 20:1-17.
See all awards »
above is two of my cats. this page is not about the cats though. this page is dedicated to Jesus. Jesus Christ is Lord. He is awesome God. He died on a cross to forgive all people of thier sins. Jesus can set you free right now today! Pray and ask Him to come into your heart and and be the Lord of your life. Receive Him as your Lord and Savior. Jesus is life! With Him you can conquer anything in your life!
I've had 2116 friends visit me.
I'm the 30,659th member on CatChannel.com.
52 friends have voted for me since I joined Club Cat!
Come visit me, Angelo, Mia, Blue Ace, Angelina, Lil Red Flame, NCK KATIE-of-SALGADO, Gabrielle & Char-lai.
Come visit me, Sassy *Please help me get 200 votes!!!*, Noah The Great, Jobey & Macho Moses.
Come visit me, Team RAGDOLL PAWesome PURRsonality #235194, :¦:Chloe:•:(¯`v´¯):•- :208036:¦: & Team CHLOE, a PAWSitively PURRfect NAME #234964.
Come visit me, Morticia.
Come visit me, Chrysanthemum.
Come visit me, Boo, Tiger & Princess.
Come visit me, Minx, Tyson, Taps & Lily.
Come visit me, bob, Gizmo & shadow.
Come visit me, Missing our sweet angels & Q. Charlotte.
Come visit me, Furrball, Garfield (R.I.P.), WildMan & Puffy.
Come visit me, Max/Jack/Emma.
Come visit me, AD Sassy - Mom Jody is home!! & Dolly- Mom Jody is home!!!.
Come visit me, patrick & sasha.
Come visit me, Chloe's Photo Gallery & Chloe (Please Read Pet Motto).
Come visit me, smokey.
Come visit me, Gidget luvs Chase - I will miss CC club cat.
Come visit me, Binx, Max & Alex.
Come visit me, Lucy.
Come visit me, Fuzz Buzz, Happy Birthday-Pickle!!! and Peaches.
Come visit me, Thunder~Missing my Charlie.... ...................., Oliver♥Daphan- e Catster ID:1133255, Verna~ - catster ID:1133550, Hermie-Cat of day on catster 7-3-10*seemotto*, Jack -catster ID:1133266, Angel Capri(1-29-10)Catste- r ID:1133561, Gidgit~plz pray4us. Mom's dad died 8-20-10... & Taz♥my wife,Gidgit.Catster ID:1132924.
Come visit me, Our Precious Angels #75646 COTD 12/3/15 WOW!, HEFTY #130639-----VFP Goalie/COTD WOW!, Honey #267035 COTD 1/25/14 THANK YOU ALL!, Handy Andy & Angel #149735, Our Angel Meezers #74302 ACOTD 2/22/15 Thank You!, Angel Zeus #246330 COTD 1/14/13!, Molly Jean #79742 COTD 4/22/15 OH MY! THANK YOU! & K.Barney #74382, COTD--- THANK YOU ALL!.
Come visit me, Velcro & V&M's Pawty Place.
Come visit me, Molly, Pumpkin, Misty Blue eyes, Micro & Lilly.
Come visit me, Samantha.
Come visit me, Emporer & Fluffy.
Come visit me, Eve, Faith & cats that have crossed the rainbow bridge.
Tell a Friend |
Report inappropriate content on this page.
Hi, my name is
Visit the photo gallery to cast your vote »
Get quick tips for happy cats, food recall info, news alerts and best behavior advice.
Sign up to get updates delivered straight to your inbox.
CatChannel takes your privacy seriously. To learn more, please read our privacy policy.


text:
Top Definition
A quick showing of one's work or goods. A visual summary.
Hey Carl, did you catch that popslice of Bob's photography?
av lorraine2009 8 september 2010
Trending Now
Can you define these popular missing words?
a swig of a drink
-Why you're so drunked?
-I caught a swig of that popslice
-I caught a swig of that popslice
av ketch-up 15 februari 2009


text:
Lifestyles Photos
Disney in full bloom during the Epcot International Flower & Garden Festival
Photo: Gene Duncan/Walt Disney World
Versailles comes to mind at the perfectly manicured parterre garden accented with geraniums at the France pavilion in the World Showcase during the Epcot International Flower & Garden Festival.
Related Content
To post a comment, log into your chosen social network and then add your comment below. Your comments are subject to our Terms of Service and the privacy policy and terms of service of your social network. If you do not want to comment with a social network, please consider writing a letter to the editor.


text:
Last Played on 99.5 Drum FM
Enjoy the comfort of radio.net for free and listen to 99.5 Drum FM easily on internet radio. You can find an extensive selection of internet radio stations and live streams from the whole world and play them with the radioplayer of radio.net. In addition to 99.5 Drum FM, you can discover plenty of other favorite stations.


text:
Documentary | Music | Musical
View trailer
Senegalese pop sensation Youssou Ndour has spent the last 20 years in the spotlight as a world-renowned musician and the iconic representative "voice of Africa." At the height of his career, Youssou became frustrated by the negative perception of his Muslim faith and composed Egypt, a deeply spiritual album dedicated to a more tolerant view of Islam. The album's brave musical message was wholeheartedly embraced by Western audiences but ignited serious religious controversy in his homeland of Senegal. The film chronicles the difficult journey Youssou must undertake to assume his true calling.


text:
Hood starts Elvis museum
By News-Argus Staff
Published in News on January 11, 2009 2:00 AM
Full Size
News-Argus/BOBBY WILLIAMS
Ryan Hood straightens an Elvis poster in his museum in a storage building behind his home in Goldsboro.
Please log in to see full story.
Other Local News
- Care in the sky: Members of the aeromedical evacuation crew fight to get injured troops back to their families


text:
Let's see if we can figure out what's causing your symptoms.
Select additional symptoms and we'll narrow your results.
Your symptoms:
- Depression
- Poor self esteem
- Problem behavior
What causes depression, poor self esteem and problem behavior? 4 possible conditions
See a list of possible causes in order from the most common to the least.
Borderline personality disorder (BPD) is a mental illness. Learn about symptoms and treatment options.
Alcoholism is also known as alcohol dependence. It occurs when you drink so much over time that your body becomes dependent on or addicted to alcohol. When this happens, alcohol use becomes the most important thing i...
Bipolar disorder mental illness marked by extreme from mania to depression. Bipolar disorder is also called bipolar disease or manic depression.
This feature is for informational purposes only and should not be used to diagnose.
Please consult a healthcare professional if you have health concerns.
Please consult a healthcare professional if you have health concerns.
Click to add a symptom to your list
- Top Symptoms
Copyright © 2005 - 2016 Healthline Media. All rights reserved for Healthline. Healthline content is strictly informational and should not be considered medical advice. See a certified medical professional for diagnosis and treatment recommendations. Terms of Use | Privacy Policy


text:
Woodstock Ave. traffic reviewedMay 06,2014Woodstock Avenue
traffic is reviewed
Traffic issues on Woodstock Avenue were attributed to a broken signal light and the continuation of daytime work on the road Monday.
The Board of Highway Commissioners held a brief meeting it adjourned after about six minutes to get an update on the status of a trial with new lane configurations that began last week.
Mayor Christopher Louras said there were problems when Rutland High School let out Monday because a signal light on Stratton Road was broken again. He also said painting was continuing on the road, and that it needed to come to an end.
Unless we get a valid test with no obstruction, its going to be hard to say yea or nay, he said. They just need to stop. They need to get out of the road. They need to get out of the right of way during the day so we can assess whats going on with the road.
Public Works Superintendent Jeffrey Wennberg said he had been assured that the daytime work on the road had concluded Monday and he expected to have data on side street traffic in another week.
The commission will discuss the lanes again at its next regular meeting Monday, following the 3 p.m. Board of Finance meeting.MORE IN This Just InBENNINGTON A Bondville woman is facing a felony charge after police said they learned she was... Full StoryBENNINGTON A local man is facing up to 50 years in jail after being arraigned earlier this... Full StoryVermont leaders face many policy challenges, chief among them demographics change, according to... Full Story
- Most Popular
- Most Emailed


text:
District News
DDESS Public Affairs Office
700 Westpark Drive
Peachtree City GA, 30269
Phone: 678-364-8044
Fax: 770-632-8720
Murray Elementary School
Fort Stewart, GA: The South Carolina/Fort Stewart/DoDDS Cuba District will open its newest school, Murray Elementary School in August of 2014. Several years have gone in to the planning and building of the school. The new school includes many innovative features and teaching and learning will emphasize the integration of technology.
Although the Fort Stewart School's enrollment will remain the same, Murray Elementary will allow the schools to re-zone, providing enrollment relief to Diamond, Brittin, and Kessler Elementary Schools. This rezoning will eliminate the need for busing, and provide easier access for student to attend schools within walking distance of their homes.
The Zoning Chart is below:


text:
Top Definition
Chafed, calloused, weathered, or blistered lips from an abnormal amount of cocksucking.
Craven Morehead could tell by her pickle lips that he had chosen a hood rat of uncommon oral prowess.
de Dr. Julius Strangepork 09 Noiembrie 2009
Trending Now
Can you define these popular missing words?
A very flamboyant teenage boy. Likes skinny jeans, long un-cut hair, paints his nails, and stands with his hands on his hips.
Conner Schrader is a total picklelips when he stands outside of Preston's bedroom door begging for forgiveness.
de thehottestbitchtowalktheearth2 04 Iulie 2011
When your best friend passes out from extreme intoxication, insert your penis between his lips as if it were a pickle.
Dude Josh passed out lets give him pickle lips.
de Jgeorge 27 Octombrie 2009
When a sexually active woman has not cleaned her vagina in several weeks. All of the sweat, cum and pussy juices from activities build up and begin to 'pickle' her labia.
Seth: Man, Jessica reeks.
Will: Yeah, I heard she's got a severe case of pickle lips.
Seth: Bruh.
Will: Yeah, I heard she's got a severe case of pickle lips.
Seth: Bruh.
de dingoatemebaby 18 Aprilie 2016


text:
By Stephen Pollard
April 21, 2010
The Mail has an excellent piece highlighting leading LibDems' history as lobbyists:
Nothing has done so much to catapult the Liberal Democrats to their
current position in the polls as Nick Clegg's passionate support for
radically reformed politics.
The Lib Dem leader was utterly unequivocal in last week's
televised debate. 'What I've supported all my adult life,' he declared,
'is a complete clean-up from top to toe in politics'.
It sounded as plausible as his manner proved persuasive. Yet it is a line remarkable chiefly for its audacious dishonesty.
Read the details here.


text:
GOSHEN, Ind. – Kelse Moon led a Davenport attack that hit .303 on the night with 14 kills while Molly Lameyer and Nicole Chase each finished with 8 kills to lead Davenport to their eighth straight win on Friday night. The Panthers defeated host Goshen College in straight sets, 25-18, 25-15, 25-18, to improve to 15-3 on the year. DU will stay in Indiana tomorrow as they take on Purdue North Central and Huntington at the HU tri-matches.
Davenport extended its winning streak to eight matches as they used a very efficient offense and solid defense to down the Maple Leafs on their home court. Lexie Spetoskey posted a team high 10 digs while Amber Getty was tops in assists with 28.
After falling behind early, DU would take the lead for good at 7-6 on a kill from Kelse Moon. The lead would grow to as many as five (22-17) before DU ended the set scoring three out of the final four to win 25-18. The Panthers connected on 17 kills in the opening set while hitting at a .432 clip.


text:
To those who lost on shorting AEGR or to longs looking for the next AEGR, look at SRPT.
You may find remarkable parallels between AEGR and SRPT and you can project SRPT share prices over the next 6-months by looking at the last 6-months of AEGR.
SRPT hasn't gone on sale yet, though working through the FDA Accelerated Approval process. That may come in July or August, then they start selling the drug & revenues will start rolling in. Then EU approval will come, expanded market, etc.
A nice dip today to get in on at SRPT as FDA AA may slip into August (3rd Q) but sill imminent. You get to buy SRPT on sale today.


text:
LAS VEGAS (AP) - Listen to Floyd Mayweather Jr.'s people and Canelo Alvarez wanted to fight their man so badly he offered to drop a few pounds to get him to sign on the dotted line.
Promoter Richard Schaefer says the truth lies somewhere in the middle.
Weight is always a big deal in fights, and it's center stage again in one of the biggest fights in recent years. Saturday night's megafight is officially for a version of the 154-pound title held by Alvarez, but will be fought at 152 pounds that will be harder for Alvarez to make than it is for Mayweather.
Copyright 2016The Associated PressAll Rights Reserved


text:
Coming September 24th, 2016:
The 17th Annual Arlington Street Fair
Event location: Raymond Avenue, between Collegeview Avenue and the Eastbound Arterial
Take part in this well-attended local tradition! Inflatable rides, live entertainment, musical guests, and 100 – plus vendors – including restaurants, shops, and craftspeople – will transform Raymond Avenue into the 16th Annual Arlington Street Fair. Admission to the fair is free and attendees will enjoy a series of scheduled events throughout the day from 12:00pm to 6:00pm. The fair reaches from the corner of Fulton and Collegeview Avenues to the Eastbound Arterial (Route 44/55).
The Arlington Street Fair is sponsored by the Arlington Business Improvement District, Vassar College and Clear Channel Radio of the Hudson Valley. For more information please email Rhianna Mirabello.
Download the Arlington Street Fair Vendor Application.


text:
Skies clearing overnight.
Cloudy skies early, then partly cloudy after midnight. Slight chance of a rain shower. Low around 55F. Winds NW at 5 to 10 mph.
Updated: September 30, 2016 @ 4:55 pm
Success! An email has been sent with a link to confirm list signup.
Error! There was an error processing your request.
Signup today!
Breaking news alerts sent right to your inbox!
Signup today! News updates sent out twice a week.
Are you a subscriber who would you like to know when the latest e-edition of The Missourian is live online? Signup today!
Sorry, there are no recent results for popular commented articles.


text:
INJURY UPDATE: #Flyers GM Paul Holmgren announced that Claude Giroux will be OUT indefinitely. FULL UPDATE HERE: http://*******/9UNv1R
Yesterday, Paul Holgmgren said that Claude Giroux was suffering "whip lash," indicating that it was a neck issue and not a concussion after getting kneed in the head over the weekend by Wayne Simmonds, but after not feeling well, it's been determined that G has a concussion.
"Claude reported not feeling very good today. Over the past few days, his symptoms have gradually gotten worse. He will be out indefinitely with a concussion," Paul Holmgren said.
As Matt wrote about last night, the NHL concussion plague rages on. With Flyers Chris Pronger and Brayden Schenn joining the likes of Sidney Crosby and Mike Richards, the number of stars watching the game from the sideline keeps rising.
Does anyone else think this is getting ridiculous? The guy is having a serious breakout year and is suddenly sidelined with a concussion.


text:
I do. Has hindered my fat loss, but it's probably not helping either. Ha
I do. Has hindered my fat loss, but it's probably not helping either. Ha
Sounds Primal to me especially if it's red wine.
I have about a week of social (i.e. alcohol consuming) events coming up. I plan on having a slightly longer then usual IF on these days, followed by a large, primal meal high in protein before the event and then going into these events with the best of intentions (sticking to wine or non-carb liquours; and eating the best options, rather then gorging).
One glass turns into the bottle, I am pretty sure that is why my results stink lately.
Just be sure to pace yourself if you are in ketosis or haven't been doing this way of eating very long....I have determined that if I'm in ketosis alcohol (even on glass of wine) hits me pretty darn hard! Everyone's different, though, but I figured I would mention it because I used to be able to drink whatever, but lately I have to go slow or else all I'm good for is falling asleep.
Enjoy your socializing!!
I just discovered that I have Atril Fibrillation and have been placed on Coumaden, which is a blood thinner.
I asked the nurse about drinking and was told not to drink too much. Well just what is too much??? She said no more than 4 beers a day. Of course, we were in the Florida Keyes. I think I can live with that.


text:
Nebraska Center for Writers
|Poet DENISE BANKER graduated from the University of Nebraska Lincoln, Concordia University, Nebraska, and took her PhD from the University of Nebraska Lincoln, where she was awarded the Academy of American Poets Award, The Louise VanSickle Award for Creative and Academic Achievement, and the Dudley Bailey Fellowship. Her work has appeared in The ALAN Review, National Council of Teachers of English; Times of Sorrow Times of Grace (Backwaters Press); Crazy Woman Creek (Houghton/Mifflin); Potato Eyes Literary Arts Journal, Prairie Schooner, and Plains Song Review. She is the author of Swimming the Colorado (Empty Bowl Press, 2012). She is a private tutor in Seattle, WA.


text:
Please read the new book refuting the Wahabi claim that "the dead do not hear' etc.
It is entitled "Deaf & Blind"
Also readable at http://www.ahlesunnat.biz/deaf.pdf
Important Announcement!
Like us on facebook!
Page 1 of 1
Deaf & Blind Refutation of Wahhabi Belief
Posted 26 October 2011 - 01:35 PM (#1)
Aqib Qadri
Share this topic:
Page 1 of 1


text:
Air Conflicts: Secret Wars
- Platforms: PC, PS3, X360
- Developer: Bitcomposer
- Publisher: Deep Silver, Kalypso Media
- Genre: Flight, Simulation
- VN:F [1.9.22_1171]User Score: 0 votes
- Add to MyGames
Air Conflicts: Secret Wars is an arcade flight simulation set in a world war I+II scenario. During the 7 campaigns the player has to fly and fight through over 48 missions. Before taking off, the player can choose between different aircrafts, each with different strengths and weaknesses.
Within the missions the player gets different objectives like patrolling, sneaking, hit & run, bombing and escorting. Objectives are presented as dialogues between different characters. After some missions the player can upgrade one of his skills in order to maneuver the airplanes easier, have more endurance or have your wingman boosted. Further, the player can choose between two control schemes. Arcade and simulation. The first one makes the game easier to control, while the second one gives more options to control the aircraft. Beside the campaign the game also features several multiplayer modes, local and via internet for up to four players
No News has been linked to this game.
No Reviews have been linked to this game.
No Specials have been linked to this game.
No Trailers have been linked to this game.
No Screenshots have been linked to this game.


text:
Product Information
The Professional's Image Restoring Digital Slide Converter.
This is the scanner that uses award-winning Kodak digital image enhancement software to convert and restore 35mm slide images to their original quality. Its magazine accepts up to 50 slides at a time, scanning them automatically one-at-a-time, enabling large-scale conversion projects, and each slide may be previewed using the built-in light panel. A full 3,600 x 3,600 dpi resolution scan--its highest setting--of a single slide takes just over two minutes, capturing all the details of the original image at 18 megapixels. Once converted, the software automatically removes surface defects such as dust and scratches from an image (after the scanner's infrared sensor detects dust), restores original colors from faded film images, and removes film grain from converted images. Images are saved onto a computer using the included USB cable. Includes Adobe Photoshop Elements 8.0 software. Works with Windows 7, Vista, XP, or Mac. Plugs into AC. 11 3/4" L x 11 1/2" W x 5" H. (5 1/2 lbs.)
SHOP.COM ReviewsWrite a Review
This product has not yet been reviewed. Be the first to write a review.